REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - MEDTRONIC INC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 4830XFIL Limited19 November 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
MEDTRONIC INC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
18-November-2014
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
35,865,386 3.64
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
3,900 0.00
Total
35,865,386 3.64
3,900 0.00
Please note that the above positions include a transfer into our accounts of 194 shares.
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(68) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
13,000
71.7039 USD/ Share
Buy
12,000
71.6797 USD/ Share
Buy
10,700
71.4384 USD/ Share
Buy
2,300
71.4774 USD/ Share
Buy
600
71.43 USD/ Share
Buy
10,400
71.4324 USD/ Share
Buy
900
71.47 USD/ Share
Buy
34,422
71.714 USD/ Share
Buy
13,300
71.7144 USD/ Share
Buy
100,000
71.7376 USD/ Share
Buy
5,700
71.6427 USD/ Share
Buy
16,502
71.715 USD/ Share
Buy
10,822
71.7239 USD/ Share
Buy
3,950
71.7368 USD/ Share
Buy
3,575
71.9218 USD/ Share
Buy
1,600
71.8434 USD/ Share
Buy
400
71.945 USD/ Share
Buy
800
71.96 USD/ Share
Buy
46,852
72.1802 USD/ Share
Buy
49,725
72.5535 USD/ Share
Buy
7,953
72.5682 USD/ Share
Buy
13,103
72.5826 USD/ Share
Buy
38,600
72.5425 USD/ Share
Buy
2,000
72.5998 USD/ Share
Buy
29,950
72.5387 USD/ Share
Buy
2,456
72.5195 USD/ Share
Buy
6,059
72.501 USD/ Share
Buy
100
71.45 USD/ Share
Buy
96
71.69 USD/ Share
Buy
100
71.85 USD/ Share
Buy
6,392
69.39 USD/ Share
Buy
1,200
69.13 USD/ Share
Buy
2,800
69.1439 USD/ Share
Buy
508
70.19 USD/ Share
Sale
1,300
71.76 USD/ Share
Buy
154
72.5591 USD/ Share
Buy
50,000
69.1006 USD/ Share
Buy
30
69.25 USD/ Share
Buy
59
69.63 USD/ Share
Buy
16
69.24 USD/ Share
Buy
23
69.20 USD/ Share
Buy
14
69.33 USD/ Share
Sale
200
71.81 USD/ Share
Sale
10,400
72.47 USD/ Share
Buy
100
72.52 USD/ Share
Sale
400
71.8725 USD/ Share
Sale
25
72.47 USD/ Share
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)YES
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Call Option
Written
500
USD 70.00
American
22 November 2014
Call Option
Written
1,000
USD 70.00
American
17 January 2015
Call Option
Written
1,000
USD 67.50
American
22 November 2014
Call Option
Written
1,400
USD 70.00
American
20 December 2014
Date of disclosure
19 November 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEEKLFFZFFXFBD
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement